A novel method using intranasal delivery of EdU demonstrates that accessory olfactory ensheathing cells respond to injury by proliferation.
Olfactory ensheathing cells (OECs) play an important role in the continuous regeneration of the primary olfactory nervous system throughout life and for regeneration of olfactory neurons after injury. While it is known that several individual OEC subpopulations with distinct properties exist in different anatomical locations, it remains unclear how these different subpopulations respond to a major injury. We have examined the proliferation of OECs from one distinct location, the peripheral accessory olfactory nervous system, following large-scale injury (bulbectomy) in mice. We used crosses of two transgenic reporter mouse lines, S100ß-DsRed and OMP-ZsGreen, to visualise OECs, and main/accessory olfactory neurons, respectively. We surgically removed one olfactory bulb including the accessory olfactory bulb to induce degeneration, and found that accessory OECs in the nerve bundles that terminate in the accessory olfactory bulb responded by increased proliferation with a peak occurring 2 days after the injury. To label proliferating cells we used the thymidine analogue ethynyl deoxyuridine (EdU) using intranasal delivery instead of intraperitoneal injection. We compared and quantified the number of proliferating cells at different regions at one and four days after EdU labelling by the two different methods and found that intranasal delivery method was as effective as intraperitoneal injection. We demonstrated that accessory OECs actively respond to widespread degeneration of accessory olfactory axons by proliferating. These results have important implications for selecting the source of OECs for neural regeneration therapies and show that intranasal delivery of EdU is an efficient and reliable method for assessing proliferation of olfactory glia.
School of Biomedical Sciences, Queensland University of Technology, 2 George St, Brisbane 4000, Queensland, Australia; Eskitis Institute for Drug Discovery, Griffith University, 170 Kessels Rd, Nathan, 4111 Brisbane, Queensland, Australia. Electronic address: fatemeh.chehrehasa@qut.edu.au.
Fatemeh
F
Chehrehasa
School of Biomedical Sciences, Queensland University of Technology, 2 George St, Brisbane 4000, Queensland, Australia; Eskitis Institute for Drug Discovery, Griffith University, 170 Kessels Rd, Nathan, 4111 Brisbane, Queensland, Australia.
Jenny A K
JA
Ekberg
Eskitis Institute for Drug Discovery, Griffith University, 170 Kessels Rd, Nathan, 4111 Brisbane, Queensland, Australia. Electronic address: j.stjohn@griffith.edu.au.
James A
JA
St John
D000281:Administration, Intranasal; D000818:Animals; D049109:Cell Proliferation; D003857:Deoxyuridine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D007202:Indicators and Reagents; D008822:Mice, Transgenic; D009457:Neuroglia / Q000473:pathology*; D009830:Olfactory Bulb / Q000293:injuries / Q000473:pathology*; D013194:Staining and Labeling
D007202:Indicators and Reagents; C022811:edoxudin; D003857:Deoxyuridine
Accessory olfactory bulb; Axon; Glia; Regeneration; Vomeronasal